×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

India Continuous Glucose Monitoring System Market

ID: MRFR/MED/48295-HCR
200 Pages
Rahul Gotadki
October 2025

India Continuous Glucose Monitoring System Market Research Report By Application (Diabetes Management, Critical Care, Sports Nutrition), By Product Type (Sensor, Transmitter, Receiver, Integrated Device), By End-user (Hospitals, Homecare, Diabetes Clinics), and By Technology (Microdialysis, Spectroscopy, Electrochemical)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

India Continuous Glucose Monitoring System Market Infographic
Purchase Options

India Continuous Glucose Monitoring System Market Summary

As per MRFR analysis, the continuous glucose monitoring system market size was estimated at 500.0 USD Million in 2024. The continuous glucose-monitoring-system market is projected to grow from 561.75 USD Million in 2025 to 1800.0 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 12.35% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The India The India continuous glucose monitoring system market is poised for substantial growth. This growth is driven by technological advancements and rising health consciousness.

  • Technological advancements are enhancing the accuracy and usability of continuous glucose-monitoring systems.
  • The largest segment in the market is the wearable devices segment, while the fastest-growing segment is anticipated to be mobile health applications.
  • Government initiatives aimed at promoting diabetes management are contributing to market expansion.
  • Increasing diabetes prevalence and rising awareness of preventive healthcare are key drivers propelling the market forward.

Market Size & Forecast

2024 Market Size 500.0 (USD Million)
2035 Market Size 1800.0 (USD Million)

Major Players

Dexcom (US), Abbott (US), Medtronic (US), Roche (CH), Senseonics (US), GlucoMe (IL), Insulet (US), Boehringer Ingelheim (DE)

India Continuous Glucose Monitoring System Market Trends

The continuous glucose monitoring system market is experiencing notable growth. This growth is driven by increasing awareness of diabetes management and the rising prevalence of diabetes in the population. The demand for innovative healthcare solutions is prompting advancements in technology, leading to the development of more efficient and user-friendly monitoring devices. As healthcare infrastructure improves, accessibility to these systems is becoming more widespread, which may further enhance patient adherence to glucose monitoring. Additionally, the integration of digital health solutions is transforming how patients interact with their health data, potentially leading to better health outcomes. Moreover, The continuous glucose monitoring system market is likely to benefit from government initiatives. These initiatives aim to promote diabetes care and management. These initiatives may include subsidies for medical devices, educational programs for patients, and collaborations with healthcare providers to ensure better access to monitoring systems. The focus on preventive healthcare is also gaining traction, which could encourage more individuals to adopt continuous monitoring as a proactive measure. Overall, the market appears poised for sustained growth, reflecting a shift towards more personalized and technology-driven healthcare solutions.

Technological Advancements

The continuous glucose-monitoring-system market is witnessing rapid technological advancements, with innovations in sensor technology and data analytics. These developments are enhancing the accuracy and reliability of glucose readings, which may lead to improved patient outcomes. Furthermore, the integration of mobile applications with monitoring devices is facilitating real-time data sharing, allowing for better management of diabetes.

Government Initiatives

Government initiatives aimed at improving diabetes care are playing a crucial role in the continuous glucose-monitoring-system market. Policies promoting awareness, education, and accessibility to monitoring devices are likely to encourage more individuals to utilize these systems. Such initiatives may include financial support for patients and partnerships with healthcare providers to enhance service delivery.

Rising Health Consciousness

There is a growing trend of health consciousness among the population, which is positively impacting the continuous glucose-monitoring-system market. As more individuals become aware of the importance of regular glucose monitoring, the demand for these systems is expected to rise. This shift towards proactive health management may lead to increased adoption of continuous monitoring technologies.

India Continuous Glucose Monitoring System Market Drivers

Increasing Diabetes Prevalence

The rising incidence of diabetes in India is a crucial driver for the continuous glucose-monitoring-system market. According to the Indian Council of Medical Research, the prevalence of diabetes has surged to approximately 8.9% among adults, indicating a growing need for effective management solutions. This alarming trend necessitates the adoption of continuous glucose monitoring systems, which provide real-time data and help patients maintain optimal glucose levels. As more individuals are diagnosed with diabetes, the demand for innovative monitoring solutions is expected to increase significantly. The continuous glucose-monitoring-system market is likely to expand as healthcare providers and patients seek advanced technologies to manage diabetes effectively, thereby improving patient outcomes and reducing long-term complications.

Growing E-commerce and Retail Channels

The expansion of e-commerce and retail channels in India is significantly impacting the continuous glucose-monitoring-system market. With the increasing penetration of the internet and smartphone usage, consumers are more inclined to purchase healthcare products online. E-commerce platforms are providing greater access to continuous glucose monitoring systems, making them more readily available to a wider audience. This trend is expected to continue, with online sales projected to grow by 25% annually in the healthcare sector. As consumers seek convenience and competitive pricing, the continuous glucose-monitoring-system market is likely to experience a boost in sales through these channels. The ability to compare products and read reviews online further enhances consumer confidence in purchasing these essential health monitoring devices.

Technological Integration in Healthcare

The integration of advanced technologies in healthcare is propelling the continuous glucose-monitoring-system market forward. Innovations such as mobile applications, cloud computing, and artificial intelligence are enhancing the functionality of glucose monitoring systems. These technologies allow for seamless data sharing between patients and healthcare providers, facilitating better management of diabetes. The Indian healthcare sector is increasingly adopting these technologies, with a projected growth rate of 30% in digital health solutions by 2025. This trend indicates a strong potential for the continuous glucose-monitoring-system market, as patients seek more efficient and user-friendly devices that can integrate with their daily lives. The ability to access real-time data and receive personalized insights is likely to drive further adoption of these systems.

Government Support and Policy Frameworks

Government initiatives and supportive policy frameworks are playing a pivotal role in the growth of the continuous glucose-monitoring-system market. The Indian government has been actively promoting diabetes management through various health programs and subsidies for medical devices. Policies aimed at improving access to healthcare technology are likely to enhance the affordability and availability of continuous glucose monitoring systems. For instance, the National Health Mission has been instrumental in increasing awareness and access to diabetes care. This supportive environment is expected to encourage manufacturers to innovate and expand their product offerings, thereby driving market growth. The continuous glucose monitoring system market stands to benefit from these initiatives. They align with national health objectives.

Rising Awareness of Preventive Healthcare

There is a growing awareness of preventive healthcare among the Indian population, which is significantly influencing the continuous glucose-monitoring-system market. As individuals become more health-conscious, they are increasingly seeking proactive measures to manage their health, particularly concerning diabetes. Educational campaigns and health initiatives by both government and private sectors are promoting the importance of regular glucose monitoring. This shift in mindset is expected to drive the demand for continuous glucose monitoring systems, as they offer a convenient and effective way to track glucose levels. The market is likely to see a surge in adoption as more people recognize the benefits of early detection and management of diabetes, potentially reducing the burden on healthcare systems.

Market Segment Insights

By Application: Diabetes Management (Largest) vs. Sports Nutrition (Fastest-Growing)

The India continuous glucose-monitoring-system market shows a clear dominance of the Diabetes Management segment, which is pivotal in the healthcare landscape. This segment holds the largest market share, reflecting the widespread prevalence of diabetes and the increasing demand for effective management solutions. In contrast, the Sports Nutrition segment, while smaller, is rapidly gaining traction as more individuals recognize the importance of monitoring glucose levels for optimal athletic performance. Growth trends in the application segment are significantly influenced by rising health awareness, advancements in technology, and changing lifestyle patterns. The Diabetes Management segment continues to thrive due to an aging population and higher incidences of diabetes, which necessitate reliable monitoring systems. Meanwhile, the Sports Nutrition segment is the fastest-growing, driven by the surge in fitness consciousness among youth and athletes seeking to optimize their health and performance outcomes. Emerging technologies and innovative products are further propelling this growth within the market.

Diabetes Management (Dominant) vs. Critical Care (Emerging)

Diabetes Management is characterized by its established presence and extensive range of products tailored for individuals managing diabetes, making it the dominant segment in the market. This segment benefits from strong consumer demand and continuous innovations, ensuring a robust growth trajectory. On the other hand, the Critical Care segment is emerging as a vital area within the market, responding to the needs of healthcare professionals in intensive care settings. It focuses on providing precise glucose monitoring in critical conditions, reflecting an increasing reliance on technology for patient care. This segment is set to grow as hospitals and healthcare facilities adopt more advanced monitoring systems to improve patient outcomes, creating a synergy between technology providers and healthcare practitioners.

By Product Type: Sensor (Largest) vs. Transmitter (Fastest-Growing)

In the India continuous glucose-monitoring-system market, the product type segmentation reveals that sensors hold the largest market share, driven primarily by their critical role in tracking glucose levels accurately and continuously. Transmitters, while smaller in market share, are witnessing rapid adoption, influenced by technological advancements that enhance data transmission efficiency and integration with digital health platforms. Growth trends indicate a significant shift towards integrated devices that streamline the user experience and promise improved patient adherence. The increasing prevalence of diabetes and the need for real-time monitoring solutions propels the demand for these products. Moreover, government initiatives promoting healthcare technology are further driving innovation and uptake in this segment.

Sensor (Dominant) vs. Transmitter (Emerging)

Sensors in the India continuous glucose-monitoring-system market are recognized for their reliability and accuracy, making them the primary choice for users. They are essential in providing real-time glucose readings, which supports better management of diabetes. On the other hand, transmitters are emerging as an important segment, facilitating seamless communication between sensors and monitoring devices. This category is gaining traction due to the push for more connected health solutions that help users track their data more efficiently. The innovative designs and enhanced functionalities of these transmitters are expected to create a strong market presence, catering to the rising demand for integrated diabetes care solutions.

By End User: Hospitals (Largest) vs. Homecare (Fastest-Growing)

In the India continuous glucose-monitoring-system market, the distribution of market share among the end user segments reveals that hospitals hold the largest share, driven by the high demand for advanced medical technologies and the supportive infrastructure available within healthcare settings. Homecare solutions are gradually gaining traction, appealing to patients preferring to manage their diabetes at home, resulting in a significant shift in user preferences. The trend toward personalized healthcare is propelling growth in the homecare segment, with advancements in technology making devices more user-friendly and accessible. Additionally, the increasing prevalence of diabetes is prompting both individuals and healthcare providers to adopt continuous glucose monitoring, further boosting the overall demand across all segments, with homecare experiencing the most rapid expansion of late.

Hospitals: Dominant vs. Homecare: Emerging

Hospitals represent a dominant force in the India continuous glucose-monitoring-system market, leveraging their established networks and capabilities to provide reliable and comprehensive care. These institutions are equipped with sophisticated monitoring systems that allow for real-time data analysis and improved patient outcomes. Conversely, the homecare segment is emerging as a significant player, facilitated by technological innovations that enable patients to conveniently monitor their glucose levels from home. This shift is driven by a desire for autonomy in diabetes management and the convenience of remote monitoring. As both segments continue to evolve, they reflect the changing landscape of healthcare delivery and the importance of adaptability to patient needs.

By Technology: Electrochemical (Largest) vs. Spectroscopy (Fastest-Growing)

The market share distribution within the continuous glucose-monitoring-system technologies reveals that electrochemical systems dominate, attributed to their efficiency and accuracy in real-time glucose measurement. Microdialysis and spectroscopy have their own niches; however, they currently hold smaller shares in comparison. Spectroscopy's adoption is growing, driven by technological advancements and increased demand for non-invasive glucose monitoring solutions. In terms of growth trends, the electrochemical segment is established and benefits from robust manufacturing and supply chain operations. Meanwhile, spectroscopy is emerging rapidly, fueled by increasing consumer awareness about diabetes management and the technological innovation that makes these systems more accessible and effective. This growth is expected to continue as healthcare providers push for more advanced glucose monitoring systems.

Technology: Electrochemical (Dominant) vs. Spectroscopy (Emerging)

Electrochemical technologies are well-recognized for their precision in glucose readings, making them the dominant force in the India continuous glucose-monitoring-system market. Their established infrastructure supports widespread adoption among consumers and healthcare providers alike. Conversely, spectroscopy represents an emerging trend in glucose monitoring, known for its potential to offer non-invasive solutions, appealing to a broader audience concerned about comfort and ease of use. The distinct characteristics of both segments cater to the diverse needs of consumers, ensuring their coexistence and growth within the dynamically evolving market.

Get more detailed insights about India Continuous Glucose Monitoring System Market

Key Players and Competitive Insights

The continuous glucose-monitoring-system market in India is characterized by a dynamic competitive landscape, driven by increasing diabetes prevalence and a growing demand for advanced monitoring solutions. Key players such as Dexcom (US), Abbott (US), and Medtronic (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Dexcom (US) focuses on innovation, particularly with its latest CGM technology that offers real-time data sharing capabilities, which appeals to tech-savvy consumers. Abbott (US), on the other hand, emphasizes affordability and accessibility, leveraging its Freestyle Libre system to penetrate diverse market segments. Medtronic (US) is strategically positioned through its integration of insulin delivery systems with CGM technology, thereby creating a comprehensive diabetes management solution. Collectively, these strategies foster a competitive environment that prioritizes technological advancement and consumer-centric solutions.

In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and enhance supply chain efficiency. This approach is particularly relevant in a moderately fragmented market where several players vie for market share. The collective influence of these key players shapes a competitive structure that encourages innovation while also addressing local consumer needs. The emphasis on optimizing supply chains and local production capabilities is likely to enhance responsiveness to market demands.

In August 2025, Abbott (US) announced a strategic partnership with a leading Indian healthcare provider to expand its Freestyle Libre distribution network across rural areas. This move is significant as it not only enhances Abbott's market reach but also addresses the critical need for diabetes management solutions in underserved regions. By focusing on accessibility, Abbott positions itself as a leader in the market, potentially increasing its user base significantly.

In September 2025, Medtronic (US) launched a new version of its CGM system that integrates artificial intelligence to provide predictive analytics for users. This innovation is crucial as it aligns with the growing trend towards personalized healthcare solutions. By incorporating AI, Medtronic enhances the user experience and improves diabetes management outcomes, thereby solidifying its competitive edge in the market.

In October 2025, Dexcom (US) unveiled a new mobile application that allows users to track their glucose levels and receive alerts in real-time. This development is indicative of the increasing importance of digital health solutions in the continuous glucose-monitoring-system market. By enhancing user engagement through technology, Dexcom not only improves customer satisfaction but also strengthens its brand loyalty in a competitive landscape.

As of November 2025, current trends in the market include a pronounced shift towards digitalization, sustainability, and the integration of AI technologies. Strategic alliances among key players are increasingly shaping the competitive landscape, fostering innovation and enhancing product offerings. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological innovation, reliability in supply chains, and enhanced consumer engagement. This shift underscores the importance of adapting to market demands while leveraging advanced technologies to maintain a competitive advantage.

Key Companies in the India Continuous Glucose Monitoring System Market market include

Industry Developments

The India Continuous Glucose Monitoring System Market has seen significant developments recently, with companies like Abbott and Dexcom leading in innovations and product launches. In July 2023, Abbott announced the local availability of its Freestyle Libre 3 system, touted for its improved accuracy and smaller size, contributing to a more user-friendly experience for diabetic patients.

Additionally, Medtronic is expanding its product offerings in India, focusing on integrating digital health solutions with its glucose monitoring systems to enhance patient care. The market is witnessing a surge in investments and a competitive landscape, with companies like Acon Labs and Nova Biomedical increasing their presence in the region.

In terms of mergers and acquisitions, details are scant as of October 2023, but continuous technological advancements and collaborations between prominent players, including Johnson and Johnson and Roche, are expected to reshape the market dynamics.

Growth in the adoption of continuous glucose monitoring technology is further fueled by rising diabetes prevalence in India, which has seen an increase in cases, prompting governmental initiatives focusing on diabetes management and awareness.

Future Outlook

India Continuous Glucose Monitoring System Market Future Outlook

The Continuous Glucose Monitoring System Market is projected to grow at a 12.35% CAGR from 2024 to 2035. This growth is driven by technological advancements, increasing diabetes prevalence, and rising health awareness.

New opportunities lie in:

  • Development of integrated mobile health applications for real-time monitoring.
  • Expansion of subscription-based models for continuous glucose data access.
  • Partnerships with healthcare providers for personalized diabetes management solutions.

By 2035, the market is expected to achieve substantial growth, driven by innovation and strategic partnerships.

Market Segmentation

India Continuous Glucose Monitoring System Market End User Outlook

  • Hospitals
  • Homecare
  • Diabetes Clinics

India Continuous Glucose Monitoring System Market Technology Outlook

  • Microdialysis
  • Spectroscopy
  • Electrochemical

India Continuous Glucose Monitoring System Market Application Outlook

  • Diabetes Management
  • Critical Care
  • Sports Nutrition

India Continuous Glucose Monitoring System Market Product Type Outlook

  • Sensor
  • Transmitter
  • Receiver
  • Integrated Device

Report Scope

MARKET SIZE 2024 500.0(USD Million)
MARKET SIZE 2025 561.75(USD Million)
MARKET SIZE 2035 1800.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 12.35% (2024 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Dexcom (US), Abbott (US), Medtronic (US), Roche (CH), Senseonics (US), GlucoMe (IL), Insulet (US), Boehringer Ingelheim (DE)
Segments Covered Application, Product Type, End User, Technology
Key Market Opportunities Integration of advanced data analytics in continuous glucose-monitoring-system market enhances personalized diabetes management solutions.
Key Market Dynamics Rising demand for continuous glucose-monitoring systems driven by increasing diabetes prevalence and technological advancements in India.
Countries Covered India

Leave a Comment

FAQs

What is the expected market size of the India Continuous Glucose Monitoring System Market in 2024?

The India Continuous Glucose Monitoring System Market is expected to be valued at 350.0 million USD in 2024.

What is the projected market size for the India Continuous Glucose Monitoring System Market by 2035?

By 2035, the projected market size of the India Continuous Glucose Monitoring System Market is anticipated to reach 1200.0 million USD.

What is the expected CAGR for the India Continuous Glucose Monitoring System Market between 2025 and 2035?

The expected CAGR for the India Continuous Glucose Monitoring System Market from 2025 to 2035 is 11.853%.

Which application segment holds the largest market share in 2024 within the India Continuous Glucose Monitoring System Market?

In 2024, the Diabetes Management application segment holds the largest market share at 200.0 million USD.

What will be the market size of the Critical Care application segment in 2035?

The market size of the Critical Care application segment is projected to reach 300.0 million USD by 2035.

Who are the key players in the India Continuous Glucose Monitoring System Market?

Key players in the India Continuous Glucose Monitoring System Market include companies such as Medtronic, Dexcom, and Abbott, among others.

What is the expected market size for the Sports Nutrition application segment by 2035?

The expected market size for the Sports Nutrition application segment is anticipated to reach 100.0 million USD by 2035.

How is the India Continuous Glucose Monitoring System Market expected to evolve in the coming years?

The market is expected to grow significantly, driven by advancements in technology and increasing demand for diabetes management solutions.

What are some challenges facing the India Continuous Glucose Monitoring System Market?

Challenges include regulatory hurdles and the need for increased awareness and accessibility among the population.

What trends are currently influencing the India Continuous Glucose Monitoring System Market?

Emerging trends include the integration of smart technology in monitoring devices and increased emphasis on personalized diabetes care.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions